Sunmax Biotechnology Statistics
Total Valuation
Sunmax Biotechnology has a market cap or net worth of TWD 14.87 billion. The enterprise value is 13.87 billion.
Market Cap | 14.87B |
Enterprise Value | 13.87B |
Important Dates
The next estimated earnings date is Monday, November 11, 2024.
Earnings Date | Nov 11, 2024 |
Ex-Dividend Date | Jul 17, 2024 |
Share Statistics
Sunmax Biotechnology has 54.46 million shares outstanding. The number of shares has increased by 0.01% in one year.
Shares Outstanding | 54.46M |
Shares Change (YoY) | +0.01% |
Shares Change (QoQ) | -0.12% |
Owned by Insiders (%) | 8.64% |
Owned by Institutions (%) | 0.72% |
Float | 49.76M |
Valuation Ratios
The trailing PE ratio is 20.92.
PE Ratio | 20.92 |
Forward PE | n/a |
PS Ratio | 8.45 |
PB Ratio | 12.48 |
P/FCF Ratio | 26.66 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.50, with an EV/FCF ratio of 24.86.
EV / Earnings | 19.48 |
EV / Sales | 7.88 |
EV / EBITDA | 13.50 |
EV / EBIT | 14.77 |
EV / FCF | 24.86 |
Financial Position
The company has a current ratio of 1.41, with a Debt / Equity ratio of 13.48.
Current Ratio | 1.41 |
Quick Ratio | 1.22 |
Debt / Equity | 13.48 |
Debt / EBITDA | 0.16 |
Debt / FCF | 0.29 |
Interest Coverage | 176.14 |
Financial Efficiency
Return on equity (ROE) is 62.86% and return on invested capital (ROIC) is 45.16%.
Return on Equity (ROE) | 62.86% |
Return on Assets (ROA) | 25.00% |
Return on Capital (ROIC) | 45.16% |
Revenue Per Employee | n/a |
Profits Per Employee | n/a |
Employee Count | n/a |
Asset Turnover | 0.75 |
Inventory Turnover | 2.78 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +44.06% in the last 52 weeks. The beta is 0.32, so Sunmax Biotechnology's price volatility has been lower than the market average.
Beta (5Y) | 0.32 |
52-Week Price Change | +44.06% |
50-Day Moving Average | 291.54 |
200-Day Moving Average | 246.49 |
Relative Strength Index (RSI) | 42.02 |
Average Volume (20 Days) | 14,602 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, Sunmax Biotechnology had revenue of TWD 1.76 billion and earned 711.78 million in profits. Earnings per share was 13.05.
Revenue | 1.76B |
Gross Profit | 1.46B |
Operating Income | 938.48M |
Pretax Income | 981.17M |
Net Income | 711.78M |
EBITDA | 994.03M |
EBIT | 938.48M |
Earnings Per Share (EPS) | 13.05 |
Balance Sheet
The company has 1.16 billion in cash and 160.57 million in debt, giving a net cash position of 1.00 billion or 18.42 per share.
Cash & Cash Equivalents | 1.16B |
Total Debt | 160.57M |
Net Cash | 1.00B |
Net Cash Per Share | 18.42 |
Equity (Book Value) | 1.19B |
Book Value Per Share | 21.88 |
Working Capital | 393.54M |
Cash Flow
In the last 12 months, operating cash flow was 646.17 million and capital expenditures -88.44 million, giving a free cash flow of 557.73 million.
Operating Cash Flow | 646.17M |
Capital Expenditures | -88.44M |
Free Cash Flow | 557.73M |
FCF Per Share | 10.24 |
Margins
Gross margin is 82.80%, with operating and profit margins of 53.33% and 40.45%.
Gross Margin | 82.80% |
Operating Margin | 53.33% |
Pretax Margin | 55.76% |
Profit Margin | 40.45% |
EBITDA Margin | 56.49% |
EBIT Margin | 53.33% |
FCF Margin | 31.69% |
Dividends & Yields
This stock pays an annual dividend of 11.00, which amounts to a dividend yield of 3.96%.
Dividend Per Share | 11.00 |
Dividend Yield | 3.96% |
Dividend Growth (YoY) | 15.79% |
Years of Dividend Growth | 5 |
Payout Ratio | 72.69% |
Buyback Yield | -0.01% |
Shareholder Yield | 3.95% |
Earnings Yield | 4.78% |
FCF Yield | 3.75% |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |